Solid Biosciences Inc.SLDBNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +106.60% | +84.63% | +73.87% | +129.98% | +127.82% |
| Weighted Average Shares Diluted Growth | +106.60% | +84.63% | +73.87% | +129.98% | +127.82% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +14.67% | +14.38% | +38.29% | +33.47% | +29.31% |
| Book Value per Share Growth | -44.00% | -41.23% | -19.63% | -41.88% | -42.72% |
| Debt Growth | -7.91% | -7.95% | -8.48% | -8.88% | -11.25% |
| R&D Expense Growth | +63.62% | +99.12% | +63.80% | +66.56% | +42.21% |
| SG&A Expenses Growth | +22.50% | +33.97% | +14.38% | +11.42% | +17.08% |